Prescription Medications

Health News Headline

Is the PSA Test Worth It? Major Study Is Inconclusive

WEDNESDAY, Aug. 6, 2014 (HealthDay News) -- The value of the PSA test to screen men for prostate cancer has long been debated, and a new study of 162,000 men may not resolve the issue.

The European study, reported Aug. 6 in The Lancet, finds that widespread use of prostate-specific antigen (PSA) blood tests does reduce deaths from the disease by about one-fifth.

Read entire article...

Warafin Warfarin Warfarina Warfarine Warfilone Wartec Creme Welbutrin Welchol	Wellbutrin Wellbutrin SR Wellcovorin Wellvone Wigraine Wilpowr Winpar Winpred	Winstrol Wintermin Wintrocin Wygesic Wymox Wytens
Some others: Amantagamma, Penglobe, Filoklin, Sentis, Enoxaparin, Captral, Natrilix Sr, Unakalm, Propranololo, Fortzaar, Clorzoxazona, Famtrex, ...
HealthCare News Heart Attack Survival Rates Rise Study Shows Improvement in Survival Rates for Medicare Patients After Heart Attack Hospitalization By Miranda Hitti WebMD Health News Reviewed By Louise Chang, MD Aug. 18, 2009 -- Americans aged 65 and older are becoming more likely tosurvive the first month after hospitalization for a heart attack. Read entire article...
Other Names

Browse Meds: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Prescription Medications

Is the PSA Test Worth It? Major Study Is Inconclusive

Heart Attack Survival Rates Rise